Compound name and sequence
The name on the label should identify the molecule unambiguously enough to be reconciled with the certificate. Peptides accumulate multiple names — laboratory codes, sequence-derived names, trade names — so the operative check is not the name but whether the certificate's mass-spectrometry result matches the theoretical mass of the sequence you believe you are buying.
Where a compound has commonly confused variants, the label should distinguish them explicitly. CJC-1295 with DAC and CJC-1295 without DAC are different molecules with different masses and pharmacokinetics; TB-500 and full-length thymosin beta-4 are likewise distinct materials. A label that omits the qualifier is an ambiguity, not a shorthand.